SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008943
Filing Date
2017-05-05
Accepted
2017-05-05 08:06:40
Documents
84
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-10q_20170331.htm 10-Q 1640262
2 EX-10.1 ctmx-ex101_883.htm EX-10.1 236169
3 EX-31.1 ctmx-ex311_9.htm EX-31.1 19573
4 EX-31.2 ctmx-ex312_6.htm EX-31.2 19603
5 EX-32.1 ctmx-ex321_7.htm EX-32.1 10150
6 EX-32.2 ctmx-ex322_8.htm EX-32.2 10538
7 GRAPHIC g201705051058474664196.jpg GRAPHIC 2846
8 GRAPHIC g201705051058474644195.jpg GRAPHIC 18851
  Complete submission text file 0001564590-17-008943.txt   6623719

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ctmx-20170331.xml EX-101.INS 1275056
10 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20170331.xsd EX-101.SCH 59355
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20170331_cal.xml EX-101.CAL 46632
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20170331_def.xml EX-101.DEF 174638
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20170331_lab.xml EX-101.LAB 383092
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20170331_pre.xml EX-101.PRE 332234
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 17816142
SIC: 2834 Pharmaceutical Preparations